Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript
My name is Gena Wang. I'm SMid-Cap Biotech Analyst at Barclays. Welcome to our Second Virtual Global Healthcare conference. First, I wish everyone, stay healthy, and I would like to thank all the participants, investor companies and especially, our event team and the corporate access team who made this virtual healthcare conference possible.
With that, I would like to introduce our next presenting company, Alnylam. With us today, we have John Maraganore, Chief Executive Officer. John, I hand over to you.
Thanks, Gena. Thank you so much. It's great to be here. Listen, in spite of the challenges that everybody had in 2020 with COVID and what it did for public health across the world, 2020 ended up being a remarkable year for Alnylam. We really embraced our challenge-accepted spirit at the company. We took it to heart, and we remain steadfast in our commitment to the patient communities that we serve.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
